<?xml version="1.0" encoding="UTF-8"?>
<p id="para390">Our study shows that the long-term outcome of the vaccination of 9-month-old infants against yellow fever is unsatisfactory and argues for the one-dose-for-life recommendation to be reconsidered for this population in endemic countries. The beneficial effect of a booster dose has been established in individuals with low or negative neutralisation titres,
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref> but little evidence focuses on children. Further studies will be necessary to plan an ideal revaccination strategy against yellow fever within the wider schedule of childhood immunisations. A booster dose of vaccine would help to attain appropriate population immunity against yellow fever outbreaks.
</p>
